This paper is in the following e-collection/theme issue:

Case Report (14) JMIR Theme Issue: COVID-19 Special Issue (2461) Outbreak and Pandemic Preparedness and Management (1743) Infectious Diseases (non-STD/STI) (1592)

Published on in Vol 5, No 4 (2022): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/41739, first published .
Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report

Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report

Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report

Authors of this article:

Fahad Ahmed1 Author Orcid Image ;   Nashwah Memon2 Author Orcid Image ;   Adel Haque3 Author Orcid Image
Article Authors Cited by (3) Tweetations (31) Metrics

Journals

  1. Baeza-Hernández G, Cañueto J. Intralesional Treatments for Invasive Cutaneous Squamous Cell Carcinoma. Cancers 2023;16(1):158 View
  2. Ilaria P, Nevena S, Ersilia T, Federica T, Felice F, Agnieszka Ewa D, Francesco F, Concetta P. Generalized Eruptive Keratoacanthoma (GEKA) after Pfizer mRNABNT162b2 (Comirnaty®) COVID-19 Vaccination Successfully Treated with Cemiplimab. Viruses 2024;16(8):1260 View
  3. Dobre A, Nedelcu R, Turcu G, Brinzea A, Struna I, Tudorache G, Ali A, Hulea I, Balasescu E, Fertig T, Gherghiceanu M, Harwood C, Ion D, Forsea A. Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm. American Journal of Clinical Dermatology 2024 View